Cargando…
Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625982/ https://www.ncbi.nlm.nih.gov/pubmed/37926718 http://dx.doi.org/10.1038/s41408-023-00937-0 |
| _version_ | 1785131247552430080 |
|---|---|
| author | Banerjee, Rahul Wang, Bo Anderson, Larry D. McCaughan, Georgia Mehra, Nikita Cowan, Andrew J. Rajkumar, S. Vincent Kaur, Gurbakhash |
| author_facet | Banerjee, Rahul Wang, Bo Anderson, Larry D. McCaughan, Georgia Mehra, Nikita Cowan, Andrew J. Rajkumar, S. Vincent Kaur, Gurbakhash |
| author_sort | Banerjee, Rahul |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10625982 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106259822023-11-07 Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians Banerjee, Rahul Wang, Bo Anderson, Larry D. McCaughan, Georgia Mehra, Nikita Cowan, Andrew J. Rajkumar, S. Vincent Kaur, Gurbakhash Blood Cancer J Correspondence Nature Publishing Group UK 2023-11-06 /pmc/articles/PMC10625982/ /pubmed/37926718 http://dx.doi.org/10.1038/s41408-023-00937-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Banerjee, Rahul Wang, Bo Anderson, Larry D. McCaughan, Georgia Mehra, Nikita Cowan, Andrew J. Rajkumar, S. Vincent Kaur, Gurbakhash Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians |
| title | Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians |
| title_full | Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians |
| title_fullStr | Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians |
| title_full_unstemmed | Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians |
| title_short | Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians |
| title_sort | once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625982/ https://www.ncbi.nlm.nih.gov/pubmed/37926718 http://dx.doi.org/10.1038/s41408-023-00937-0 |
| work_keys_str_mv | AT banerjeerahul onceweeklybortezomibasthestandardofcareinmultiplemyelomaresultsfromaninternationalsurveyofphysicians AT wangbo onceweeklybortezomibasthestandardofcareinmultiplemyelomaresultsfromaninternationalsurveyofphysicians AT andersonlarryd onceweeklybortezomibasthestandardofcareinmultiplemyelomaresultsfromaninternationalsurveyofphysicians AT mccaughangeorgia onceweeklybortezomibasthestandardofcareinmultiplemyelomaresultsfromaninternationalsurveyofphysicians AT mehranikita onceweeklybortezomibasthestandardofcareinmultiplemyelomaresultsfromaninternationalsurveyofphysicians AT cowanandrewj onceweeklybortezomibasthestandardofcareinmultiplemyelomaresultsfromaninternationalsurveyofphysicians AT rajkumarsvincent onceweeklybortezomibasthestandardofcareinmultiplemyelomaresultsfromaninternationalsurveyofphysicians AT kaurgurbakhash onceweeklybortezomibasthestandardofcareinmultiplemyelomaresultsfromaninternationalsurveyofphysicians |